Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Naomi Deirdre Fisher, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HL089570 (FISHER, NAOMI D) Jan 1, 2009 - Dec 31, 2013
    Flavanol-Rich Cocoa, Vascular Responses and Mechanisms
    Role: Principal Investigator
  2. R03AG023896 (FISHER, NAOMI D) Apr 1, 2005 - Mar 31, 2008
    Role: Principal Investigator
  3. K23AG000802 (FISHER, NAOMI D) Sep 30, 1998 - Aug 31, 2004
    Role: Principal Investigator
  4. K08AG000802 (FISHER, NAOMI D) Sep 30, 1998 - Aug 31, 2003
    Role: Principal Investigator
  5. P50HL055000 (WILLIAMS, GORDON H) Feb 1, 1996 - Jan 31, 2007
    Role: Co-Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, Bloch M, Böhm M, Sharp ASP, Schmieder RE, Azizi M, Schlaich MP, Papademetriou V, Kirtane AJ, Daemen J, Pathak A, Ukena C, Lurz P, Grassi G, Myers M, Finn AV, Morice MC, Mehran R, Jüni P, Stone GW, Krucoff MW, Whelton PK, Tsioufis K, Cutlip DE, Spitzer E. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium. Circulation. 2022 Mar 15; 145(11):847-863. PMID: 35286164.
    Citations:    Fields:    
  2. Fisher NDL, Kirtane AJ, Daemen J, Rader F, Lobo MD, Saxena M, Abraham J, Schmieder RE, Sharp ASP, Gosse P, Claude L, Song Y, Azizi M. Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial. J Hypertens. 2022 02 01; 40(2):221-228. PMID: 34433763.
    Citations:    Fields:    Translation:Humans
  3. Vitale RJ, Valtis YK, McDonnell ME, Palermo NE, Fisher NDL. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors. AACE Clin Case Rep. 2021 Jan-Feb; 7(1):10-13. PMID: 33521255.
    Citations: 13     
  4. Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, Bloch MJ, Basile J, Weber MA, Rump LC, Levy T, Sapoval M, Sanghvi K, Rader F, Fisher NDL, Gosse P, Abraham J, Claude L, Barman NC, McClure CK, Liu Y, Kirtane AJ. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation. JACC Cardiovasc Interv. 2020 12 28; 13(24):2922-2933. PMID: 33357531.
    Citations: 5     Fields:    Translation:Humans
  5. Scirica BM, Cannon CP, Fisher NDL, Gaziano TA, Zelle D, Chaney K, Miller A, Nichols H, Matta L, Gordon WJ, Murphy S, Wagholikar KB, Plutzky J, MacRae CA. Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control. Circulation. 2021 02 02; 143(5):507-509. PMID: 33201729.
    Citations: 6     Fields:    Translation:Humans
  6. Williams GH, Fisher NDL, Epstein M. Norman K. Hollenberg: 1936-2020. Hypertension. 2020 Aug; 76(2):288-290. PMID: 32536278.
    Citations:    Fields:    
  7. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial. Circulation. 2019 Mar 17. PMID: 30880441.
    Citations: 22     Fields:    
  8. Fisher NDL, Fera LE, Dunning JR, Desai S, Matta L, Liquori V, Pagliaro J, Pabo E, Merriam M, MacRae CA, Scirica BM. Development of an entirely remote, non-physician led hypertension management program. Clin Cardiol. 2019 Feb; 42(2):285-291. PMID: 30582181.
    Citations: 9     Fields:    Translation:Humans
  9. Fisher NDL, Curfman G. Hypertension-A Public Health Challenge of Global Proportions. JAMA. 2018 11 06; 320(17):1757-1759. PMID: 30398584.
    Citations: 32     Fields:    Translation:HumansPHPublic Health
  10. Beckman JA, Hurwitz S, Fisher NDL. Arginine impairs endothelial and executive function in older subjects with cardiovascular risk. J Am Soc Hypertens. 2018 10; 12(10):723-731. PMID: 30057253.
    Citations: 2     Fields:    
  11. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018 06 09; 391(10137):2335-2345. PMID: 29803590.
    Citations: 127     Fields:    Translation:HumansCTClinical Trials
  12. Fisher NDL, Orav EJ, Chang G. Effects of alcohol consumption on blood pressure in hypertensive women. Am J Drug Alcohol Abuse. 2018; 44(2):200-205. PMID: 28806102.
    Citations: 4     Fields:    Translation:Humans
  13. McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial. J Hypertens. 2017 04; 35(4):822-829. PMID: 28033130.
    Citations: 25     Fields:    Translation:Humans
  14. McMullan CJ, Borgi L, Fisher N, Curhan G, Forman J. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial. Clin J Am Soc Nephrol. 2017 May 08; 12(5):807-816. PMID: 28320765.
    Citations: 28     Fields:    Translation:HumansCells
  15. Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP. Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial. Hypertension. 2017 02; 69(2):243-248. PMID: 28028194.
    Citations: 20     Fields:    Translation:Humans
  16. Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP. Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial. Am J Hypertens. 2017 Feb; 30(2):124-129. PMID: 28077419.
    Citations: 8     Fields:    Translation:Humans
  17. Barkoudah E, van Thiel BS, Fisher ND, Gregg RA, Danser AH, Moukarbel GV, Hollenberg NK. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren. J Hypertens. 2016 May; 34(5):935-41. PMID: 26882043.
    Citations:    Fields:    Translation:Humans
  18. Sorond FA, Hurwitz S, Salat DH, Greve DN, Fisher ND. Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people. Neurology. 2013 Sep 03; 81(10):904-9. PMID: 23925758.
    Citations: 49     Fields:    Translation:HumansAnimalsCells
  19. Fisher ND, Hurwitz S, Hollenberg NK. Habitual flavonoid intake and endothelial function in healthy humans. J Am Coll Nutr. 2012 Aug; 31(4):275-9. PMID: 23378455.
    Citations: 7     Fields:    Translation:HumansAnimals
  20. Hollenberg NK, Fisher ND, Nussberger J, Moukarbel GV, Barkoudah E, Danser AH. Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? J Hypertens. 2011 Dec; 29(12):2454-61. PMID: 22002336.
    Citations: 10     Fields:    Translation:Humans
  21. Fisher ND, Meagher EA. Renin inhibitors. J Clin Hypertens (Greenwich). 2011 Sep; 13(9):662-6. PMID: 21896147.
    Citations: 4     Fields:    Translation:Humans
  22. Chang G, Fisher ND, Hornstein MD, Jones JA, Hauke SH, Niamkey N, Briegleb C, Orav EJ. Brief intervention for women with risky drinking and medical diagnoses: a randomized controlled trial. J Subst Abuse Treat. 2011 Sep; 41(2):105-14. PMID: 21489738.
    Citations: 12     Fields:    Translation:Humans
  23. Chang G, Fisher ND, Hornstein MD, Jones JA, Orav EJ. Identification of risk drinking women: T-ACE screening tool or the medical record. J Womens Health (Larchmt). 2010 Oct; 19(10):1933-9. PMID: 20839966.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  24. Sorond FA, Hollenberg NK, Panych LP, Fisher ND. Brain blood flow and velocity: correlations between magnetic resonance imaging and transcranial Doppler sonography. J Ultrasound Med. 2010 Jul; 29(7):1017-22. PMID: 20587424.
    Citations: 30     Fields:    Translation:Humans
  25. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010 May; 55(5):1283-8. PMID: 20351344.
    Citations: 115     Fields:    Translation:Humans
  26. Robinson ES, Fisher ND, Forman JP, Curhan GC. Physical activity and albuminuria. Am J Epidemiol. 2010 Mar 01; 171(5):515-21. PMID: 20133515.
    Citations: 19     Fields:    Translation:Humans
  27. Splenser AE, Fisher ND, Danser AH, Hollenberg NK. Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren. J Am Soc Hypertens. 2009 Sep-Oct; 3(5):315-20. PMID: 20409974.
    Citations: 2     Fields:    
  28. Schopick EL, Fisher ND, Lin J, Forman JP, Curhan GC. Post-menopausal hormone use and albuminuria. Nephrol Dial Transplant. 2009 Dec; 24(12):3739-44. PMID: 19574340.
    Citations: 11     Fields:    Translation:Humans
  29. Cooper Worobey C, Fisher ND, Cox D, Forman JP, Curhan GC. Genetic polymorphisms and the risk of accelerated renal function decline in women. PLoS One. 2009; 4(3):e4787. PMID: 19274077.
    Citations: 3     Fields:    Translation:Humans
  30. Hollenberg NK, Fisher ND, McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens. 2009 Mar-Apr; 3(2):105-12. PMID: 20409950.
    Citations: 22     Fields:    
  31. Krop M, Garrelds IM, de Bruin RJ, van Gool JM, Fisher ND, Hollenberg NK, Jan Danser AH. Aliskiren accumulates in Renin secretory granules and binds plasma prorenin. Hypertension. 2008 Dec; 52(6):1076-83. PMID: 18981317.
    Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
  32. Lee JM, Pou K, Sadow PM, Chen H, Hu B, Hewison M, Adams JS, Sugarbaker DJ, Fisher ND. Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma. Endocr Pract. 2008 Nov; 14(8):1011-6. PMID: 19095601.
    Citations: 3     Fields:    Translation:Humans
  33. Patel TV, Williams GH, Fisher ND. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients. J Hypertens. 2008 Jul; 26(7):1353-9. PMID: 18551010.
    Citations: 3     Fields:    Translation:Humans
  34. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol. 2008 Oct; 19(10):1983-8. PMID: 18579639.
    Citations: 40     Fields:    Translation:Humans
  35. Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation. 2008 Jun 24; 117(25):3199-205. PMID: 18559696.
    Citations: 50     Fields:    Translation:HumansCTClinical Trials
  36. Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC. Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors. J Clin Hypertens (Greenwich). 2008 Jun; 10(6):459-66. PMID: 18550936.
    Citations: 4     Fields:    Translation:Humans
  37. Sorond FA, Lipsitz LA, Hollenberg NK, Fisher ND. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat. 2008 Apr; 4(2):433-40. PMID: 18728792.
    Citations: 39     
  38. Danser AH, Charney A, Feldman DL, Nussberger J, Fisher N, Hollenberg N. The renin rise with aliskiren: it's simply stoichiometry. Hypertension. 2008 Apr; 51(4):e27-8; author reply e29. PMID: 18285609.
    Citations: 7     Fields:    Translation:Humans
  39. Hollenberg NK, Fisher ND. Is it the dark in dark chocolate? Circulation. 2007 Nov 20; 116(21):2360-2. PMID: 18025400.
    Citations: 8     Fields:    Translation:HumansAnimals
  40. Ahmed SB, Fisher ND, Hollenberg NK. Gender and the renal nitric oxide synthase system in healthy humans. Clin J Am Soc Nephrol. 2007 Sep; 2(5):926-31. PMID: 17702739.
    Citations: 12     Fields:    Translation:Humans
  41. Stevanovic RD, Fisher ND, Lansang CM, Freeman KD, Hollenberg NK. Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus. J Renin Angiotensin Aldosterone Syst. 2007 Jun; 8(2):85-92. PMID: 17703435.
    Citations:    Fields:    Translation:Humans
  42. Forman JP, Price DA, Stevanovic R, Fisher ND. Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan. J Hypertens. 2007 Apr; 25(4):877-82. PMID: 17351382.
    Citations: 6     Fields:    Translation:Humans
  43. Stankovic AR, Fisher ND, Hollenberg NK. Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J Am Soc Nephrol. 2006 Dec; 17(12):3293-9. PMID: 17093063.
    Citations: 7     Fields:    Translation:Humans
  44. Fisher ND, Hollenberg NK. Aging and vascular responses to flavanol-rich cocoa. J Hypertens. 2006 Aug; 24(8):1575-80. PMID: 16877960.
    Citations: 37     Fields:    Translation:HumansAnimals
  45. Fisher ND, Sorond FA, Hollenberg NK. Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol. 2006; 47 Suppl 2:S210-4. PMID: 16794460.
    Citations: 35     Fields:    Translation:HumansAnimals
  46. Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension. 2005 Dec; 46(6):1316-20. PMID: 16286575.
    Citations: 19     Fields:    Translation:Humans
  47. Stevanovic RD, Price DA, Lansang MC, Fisher ND, Laffel LM, Hollenberg NK. Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus. J Renin Angiotensin Aldosterone Syst. 2005 Sep; 6(2):78-83. PMID: 16470486.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  48. Fisher ND, Hollenberg NK. Flavanols for cardiovascular health: the science behind the sweetness. J Hypertens. 2005 Aug; 23(8):1453-9. PMID: 16003167.
    Citations: 6     Fields:    Translation:HumansAnimals
  49. Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care. 2005 Aug; 28(8):1988-94. PMID: 16043743.
    Citations: 20     Fields:    Translation:Humans
  50. Agarwal A, Williams GH, Fisher ND. Genetics of human hypertension. Trends Endocrinol Metab. 2005 Apr; 16(3):127-33. PMID: 15808811.
    Citations: 37     Fields:    Translation:Humans
  51. Fisher ND, Hollenberg NK. Renin inhibition: what are the therapeutic opportunities? J Am Soc Nephrol. 2005 Mar; 16(3):592-9. PMID: 15703270.
    Citations: 31     Fields:    Translation:Humans
  52. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, Hollenberg NK, Fisher ND. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004 Oct; 66(4):1465-70. PMID: 15458439.
    Citations: 52     Fields:    Translation:Humans
  53. Hollenberg NK, Stevanovic R, Agarwal A, Lansang MC, Price DA, Laffel LM, Williams GH, Fisher ND. Plasma aldosterone concentration in the patient with diabetes mellitus. Kidney Int. 2004 Apr; 65(4):1435-9. PMID: 15086486.
    Citations: 29     Fields:    Translation:Humans
  54. Fisher NDL, Williams GH. Hypertensive Vascular Disease. Harrison’s Principles of Internal Medicine. 2004; 1463-1481.
  55. Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003 Dec; 21(12):2281-6. PMID: 14654748.
    Citations: 102     Fields:    Translation:HumansAnimals
  56. Price DA, Fisher ND. The renin-angiotensin system in blacks: active, passive, or what? Curr Hypertens Rep. 2003 Jun; 5(3):225-30. PMID: 12724055.
    Citations: 20     Fields:    Translation:Humans
  57. Hurwitz S, Fisher ND, Ferri C, Hopkins PN, Williams GH, Hollenberg NK. Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens. 2003 May; 21(5):951-9. PMID: 12714870.
    Citations: 15     Fields:    Translation:Humans
  58. Hollenberg NK, Price DA, Fisher ND, Lansang MC, Perkins B, Gordon MS, Williams GH, Laffel LM. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int. 2003 Jan; 63(1):172-8. PMID: 12472780.
    Citations: 31     Fields:    Translation:HumansCTClinical Trials
  59. Price DA, Lansang MC, Osei SY, Fisher ND, Laffel LM, Hollenberg NK. Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabet Med. 2002 Oct; 19(10):858-61. PMID: 12358875.
    Citations: 3     Fields:    Translation:Humans
  60. Price DA, Fisher ND, Lansang MC, Stevanovic R, Williams GH, Hollenberg NK. Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension. 2002 Aug; 40(2):186-9. PMID: 12154111.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  61. Hopkins PN, Hunt SC, Jeunemaitre X, Smith B, Solorio D, Fisher ND, Hollenberg NK, Williams GH. Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation. 2002 Apr 23; 105(16):1921-7. PMID: 11997278.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  62. Fisher ND, Hurwitz S, Jeunemaitre X, Hopkins PN, Hollenberg NK, Williams GH. Familial aggregation of low-renin hypertension. Hypertension. 2002 Apr; 39(4):914-8. PMID: 11967249.
    Citations: 10     Fields:    Translation:Humans
  63. Fisher ND, Hurwitz S, Jeunemaitre X, Price DA, Williams GH, Hollenberg NK. Adrenal response to angiotensin II in black hypertension: lack of sexual dimorphism. Hypertension. 2001 Sep; 38(3):373-8. PMID: 11566907.
    Citations: 2     Fields:    Translation:Humans
  64. Lansang MC, Price DA, Laffel LM, Osei SY, Fisher ND, Erani D, Hollenberg NK. Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int. 2001 Apr; 59(4):1432-8. PMID: 11260405.
    Citations: 10     Fields:    Translation:Humans
  65. Fisher ND, Hollenberg NK. Is there a future for renin inhibitors? Expert Opin Investig Drugs. 2001 Mar; 10(3):417-26. PMID: 11227042.
    Citations: 12     Fields:    Translation:HumansAnimals
  66. Price DA, Fisher ND, Osei SY, Lansang MC, Hollenberg NK. Renal perfusion and function in healthy African Americans. Kidney Int. 2001 Mar; 59(3):1037-43. PMID: 11231358.
    Citations: 13     Fields:    Translation:Humans
  67. Hollenberg NK, Anzalone DA, Falkner B, Fisher ND, Hopkins PN, Hsueh W, Hutchinson H, Krauss RM, Price DA, Raskin P, Reaven GM. Familial factors in the antihypertensive response to lisinopril. Am J Hypertens. 2001 Mar; 14(3):218-23. PMID: 11281232.
    Citations: 1     Fields:    Translation:Humans
  68. Hollenberg NK, Osei SY, Lansang MC, Price DA, Fisher ND. Salt intake and non-ACE pathways for intrarenal angiotensin II generation in man. J Renin Angiotensin Aldosterone Syst. 2001 Mar; 2(1):14-8. PMID: 11881058.
    Citations: 3     Fields:    Translation:Humans
  69. Fisher ND. Web alert. Personal web sites: how to hang your shingle on the Internet. Curr Hypertens Rep. 2001 Feb; 3(1):3-5. PMID: 11357811.
    Citations:    Fields:    Translation:Humans
  70. Fisher ND. Web alert. Curr Hypertens Rep. 2000 Dec; 2(6):500-2. PMID: 11186615.
    Citations:    Fields:    Translation:HumansAnimals
  71. Lansang MC, Osei SY, Price DA, Fisher ND, Hollenberg NK. Renal hemodynamic and hormonal responses to the angiotensin II antagonist candesartan. Hypertension. 2000 Nov; 36(5):834-8. PMID: 11082152.
    Citations: 5     Fields:    Translation:Humans
  72. Fisher ND. We alert. Clinical hypertension guidelines on the web. Curr Hypertens Rep. 2000 Oct; 2(5):423-5. PMID: 11203019.
    Citations:    Fields:    
  73. Fisher ND. Web alert. Clinical trials in hypertension: guides on the internet. Curr Hypertens Rep. 2000 Aug; 2(4):345-6. PMID: 11203018.
    Citations:    Fields:    
  74. Hollenberg NK, Fisher ND, Price DA, Williams GH. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet. Am J Hypertens. 2000 May; 13(5 Pt 1):498-503. PMID: 10826400.
    Citations: 1     Fields:    Translation:Humans
  75. Williams GH, Fisher ND, Hunt SC, Jeunemaitre X, Hopkins PN, Hollenberg NK. Effects of gender and genotype on the phenotypic expression of nonmodulating essential hypertension. Kidney Int. 2000 Apr; 57(4):1404-7. PMID: 10760074.
    Citations: 4     Fields:    Translation:Humans
  76. Fisher ND. Web alert. Keeping up with medical news: daily health headlines on the Internet. Curr Hypertens Rep. 2000 Apr; 2(2):120-1. PMID: 11203017.
    Citations:    Fields:    
  77. Giacché M, Vuagnat A, Hunt SC, Hopkins PN, Fisher ND, Azizi M, Corvol P, Williams GH, Jeunemaitre X. Aldosterone stimulation by angiotensin II : influence of gender, plasma renin, and familial resemblance. Hypertension. 2000 Mar; 35(3):710-6. PMID: 10720583.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  78. Fisher ND. Web alert. Internet guide to hypertension associations and publications. Curr Hypertens Rep. 2000 Feb; 2(1):3-4. PMID: 11203016.
    Citations:    Fields:    
  79. Fisher ND. Hypertension chat: tips for your patients. Curr Hypertens Rep. 1999 Dec; 1(6):463-4. PMID: 11041674.
    Citations:    Fields:    Translation:Humans
  80. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, Passan DR, Williams GH, Hollenberg NK. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol. 1999 Nov; 10(11):2382-91. PMID: 10541298.
    Citations: 70     Fields:    Translation:Humans
  81. Fisher ND, Hurwitz S, Ferri C, Jeunemaitre X, Hollenberg NK, Williams GH. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension. 1999 Sep; 34(3):388-94. PMID: 10489382.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  82. Fisher ND, Price DA, Litchfield WR, Williams GH, Hollenberg NK. Renal response to captopril reflects state of local renin system in healthy humans. Kidney Int. 1999 Aug; 56(2):635-41. PMID: 10432403.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  83. Fisher ND. Surfing from scratch: an introduction to medical searches on the Internet. Curr Hypertens Rep. 1999 Aug; 1(4):279-80. PMID: 10981079.
    Citations:    Fields:    
  84. Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Am J Hypertens. 1999 Apr; 12(4 Pt 1):348-55. PMID: 10232494.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  85. Osei SY, Price DA, Fisher ND, Porter L, Laffel LM, Hollenberg NK. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Hypertension. 1999 Jan; 33(1 Pt 2):559-64. PMID: 9931165.
    Citations: 6     Fields:    Translation:Humans
  86. Hollenberg NK, Fisher ND, Price DA. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension. 1998 Sep; 32(3):387-92. PMID: 9740600.
    Citations: 51     Fields:    Translation:HumansAnimals
  87. Litchfield WR, Hunt SC, Jeunemaitre X, Fisher ND, Hopkins PN, Williams RR, Corvol P, Williams GH. Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. Hypertension. 1998 Feb; 31(2):569-74. PMID: 9461223.
    Citations: 16     Fields:    Translation:Humans
  88. De'Oliveira JM, Price DA, Fisher ND, Allan DR, McKnight JA, Williams GH, Hollenberg NK. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int. 1997 Sep; 52(3):771-7. PMID: 9291199.
    Citations: 21     Fields:    Translation:Humans
  89. Price DA, De'Oliveira JM, Fisher ND, Hollenberg NK. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men. Hypertension. 1997 Aug; 30(2 Pt 1):240-6. PMID: 9260987.
    Citations: 7     Fields:    Translation:Humans
  90. Fisher ND, Ferri C, Bellini C, Santucci A, Gleason R, Williams GH, Hollenberg NK, Seely EW. Age, gender, and non-modulation. A sexual dimorphism in essential hypertension. Hypertension. 1997 Apr; 29(4):980-5. PMID: 9095087.
    Citations: 9     Fields:    Translation:Humans
  91. Williams GH, Fisher ND. Genetic approach to diagnostic and therapeutic decisions in human hypertension. Curr Opin Nephrol Hypertens. 1997 Mar; 6(2):199-204. PMID: 9146984.
    Citations: 5     Fields:    Translation:HumansAnimals
  92. Hollenberg NK, Fisher ND. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word? Hypertension. 1995 Oct; 26(4):602-9. PMID: 7558219.
    Citations: 10     Fields:    Translation:HumansAnimals
  93. Fisher ND, Allan DR, Gaboury CL, Hollenberg NK. Intrarenal angiotensin II formation in humans. Evidence from renin inhibition. Hypertension. 1995 May; 25(5):935-9. PMID: 7737730.
    Citations: 2     Fields:    Translation:Humans
  94. Fisher ND, Hollenberg N. Renal vascular responses to renin inhibition with zankiren in men. Clin Pharmacol Ther. 1995 Mar; 57(3):342-8. PMID: 7697952.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  95. Fisher ND, Gleason RE, Moore TJ, Williams GH, Hollenberg NK. Regulation of aldosterone secretion in hypertensive blacks. Hypertension. 1994 Feb; 23(2):179-84. PMID: 8307626.
    Citations: 12     Fields:    Translation:Humans
  96. Fisher ND, Allan D, Kifor I, Gaboury CL, Williams GH, Moore TJ, Hollenberg NK. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans. Hypertension. 1994 Jan; 23(1):44-51. PMID: 8282330.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  97. Cordero P, Fisher ND, Moore TJ, Gleason R, Williams GH, Hollenberg NK. Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans. Hypertension. 1991 Apr; 17(4):510-6. PMID: 2013477.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Fisher's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (277)
Co-Authors (35)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.